Katater İlişkili Üriner Sistem Enfeksiyonlarında Mortalite ile İlişkili Faktörlerin Değerlendirilmesi: 5 Yıllık Retrosepektif Çalışma

Yıl 2023, Cilt: 18 Sayı: 1, 145 - 152, 16.03.2023

İlker Ödemiş , Ayfer İmre

https://doi.org/10.17517/ksutfd.1146548

Cited By: 2

Öz

Amaç: Bu çalışmanın amacı, kateter ilişkili üriner sistem enfeksiyonlarında (Kİ-ÜSİ) mortalite ile epidemiyolojik faktörler, komorbid durumlar, antibiyotik
direnci, ampirik antimikrobiyal tedavi ve laboratuvar parametreleri arasındaki ilişkiyi değerlendirmektir.
Gereç ve Yöntemler: Yoğun bakım ünitesine 1 Ocak 2015 ile 1 Ocak 2020 arasında kabul edilen 18 yaş ve üzeri hastalarda retrospektif bir kohort çalışması
tasarlanmıştır. Birincil sonlanım noktası hastanın kabulünün ilk 28 günü içinde ölüm, ikincil sonlanım noktası ise 28. günden sonra sağkalımdı. p<0.05
değeri istatistiksel olarak anlamlı kabul edildi.
Bulgular: Çalışmaya medyan yaşı 78, 198’i (%52.8) kadın toplam 375 hasta alındı. En sık saptanan mikroorganizmalar Escherichia coli (%50.9) ve Enterococcus
faecalis (%16.8)’idi. Gram negatif bakterilerin üçüncü kuşak sefalosporinlere, siprofloksasine ve meropeneme direnci sırasıyla %41.3, %40 ve %8.6
saptandı. Gram pozitif bakterilerin %0.3’ünde vankomisin direnci tespit edildi.
Mortalite oranı %58.1 idi. Artmış mortalite riski ile ilişkili faktörler ≥65 yaş, malignite varlığı, mekanik ventilasyon, APACHE II skoru ≥20 ve septik şok
tanısıydı. Daha düşük ölüm riski ile ilişkili tek faktör kültürde E. coli’nin saptanmasıydı.
Sonuç: Yaşlılığın, malignitenin, klinik skorlama sistemlerinin ve mikrobiyolojik sonuçların mortalite üzerine etkisi olduğu belirlendi. Bu çalışmanın sonuçları,
kılavuzlarda yer alan enfeksiyon kontrol önlemleri ve tedavi önerileri ile birlikte değerlendirildiğinde, Kİ-ÜSİ’ye bağlı mortalitenin azaltılabileceğini
düşünmekteyiz..

Anahtar Kelimeler

Üriner kanal enfeksiyonları, idrar yolu kateterleri, ölüm oranı, antibiyotikler, ilaç direnci, kateter kaynaklı enfeksiyonlar

Destekleyen Kurum

yok

Evaluation of Factors Associated With Mortality in Catheter-Related Urinary Tract Infections: A 5-Year Retrospective Study

Öz

Objective: The aim of the study is to evaluate the relationship between mortality and epidemiological factors, comorbid conditions, antibiotic resistance,
empirical antimicrobial therapy, and laboratory parameters in catheter-associated urinary tract infections (CAUTI).
Materials and Methods: A retrospective cohort study was designed in patients aged ≥18 years admitted to intensive care unit between 1st Jan 2015 and
1st Jan 2020. The primary endpoint was death within the first 28 days of admission, while the secondary endpoint was survival after 28 days. p value <0.05
was considered statistically significant.
Results: A total of 375 patients with a median age of 78 were included in the study; 198 (52.8%) were female. The most commonly detected microorganisms
were Escherichia coli (50.9%) and Enterococcus faecalis (16.8%). Resistance to third generation cephalosporin, ciprofloxacin, and meropenem was found
in 41.3%, 40%, and 8.6% of Gram-negative bacteria, respectively. Vancomycin resistance was detected in 0.3% of the Gram-positive bacteria.
The mortality rate was 58.1%. Factors associated with an increased risk of mortality were age ≥65 years, presence of malignancy, mechanical ventilation,
APACHE II score ≥20, and a diagnosis of septic shock. The only factor associated with the lower mortality risk was the detection of E. coli in culture.
Conclusion: It was determined that aging, malignancy, clinical scoring systems and microbiological results had an effect on mortality. Considering the
results of this study together with the infection control measures, and treatment recommendations in the guidelines, we think that mortality due to CAUTI
can be reduced.

Anahtar Kelimeler

Urinary tract infections, urinary catheters, mortality, antibiotics, drug resistance, catheter-related infections

Kaynakça

• Hooton TM, Bradley SF, Cardenas DD, Colgan R, Geerlings SE, Rice JC et al. Diagnosis, prevention, and treatment of catheter-aassociated urinary tract infection in adults: 2009 international clinical practice guidelines from the infectious diseases society of America. Clin Infect Dis. 2010;50(5):625–663.
• Keten D, Aktaş F. Catheter-associated urinary tract infections. Klimik Derg. 2014;27(2):38–47.
• Saint S. Clinical and economic consequences of nosocomial catheter-related bacteriuria. Am J Infect Control. 2000;28(1):68–75.
• Üzen Cura Ş, Arslan ŞF, Özkan E, Dönmez E, Soğlu E, Kaya HG. Üriner Kateteri Olan Hastaların Katetere İlişkin Bilgi ve Uygulamalarının İncelenmesi.Journal of Health Sciences. 2020;5(2):240-248.
• Gould C V, Umscheid CA, Agarwal RK, Kuntz G, Pegues DA. Guideline for prevention of catheter-associated urinary tract infections 2009. Infect Control Hosp Epidemiol. 2010;31(4):319–326.
• Hollenbeak CS, Schilling AL. The attributable cost of catheter-associated urinary tract infections in the United States: A systematic review. Am J Infect Control. 2018;46(7):751–757.
• Mitchell BG, Ferguson JK, Anderson M, Sear J, Barnett A. Length of stay and mortality associated with healthcare-associated urinary tract infections: A multi-state model. J Hosp Infect. 2016;93(1):92–99.
• Babich T, Zusman O, Elbaz M, Ben-Zvi H, Paul M, Leibovici L et al. Empirical Antibiotic treatment does not ımprove outcomes in catheter-associated urinary tract ınfection: prospective cohort study. Clin Infect Dis. 2017;65(11):1799–1805.
• Hekimoğlu CH, Şahan S. Üriner kateter ilişkili üriner sistem enfeksiyonlarında ölüm ile ilişkili faktörlerin incelenmesi Investigation of death related factors in urinary catheter-associated urinary tract infections. Turk Hij Den Biyol Derg. 2020;77(3):325–332.
• The European Committee on Antimicrobial Susceptibility Testing (EUCAST). Breakpoint tables for interpretation of MICs and zone diameters 2019 2019. https://www.eucast.org/fileadmin/src/media/PDFs/EUCAST_files/Breakpoint_tables/v_9.0_Breakpoint_Tables.pdf. Accessed May 26, 2022
• Li F, Song M, Xu L, Deng B, Zhu S, Li X. Risk factors for catheter-associated urinary tract infection among hospitalized patients: A systematic review and meta-analysis of observational studies. J Adv Nurs. 2019;75(3):517–527.
• Clec’h C, Schwebel C, Français A, Toledano D, Fosse J-P, Garrouste-Orgeas M et al. Does Catheter-Associated Urinary Tract Infection Increase Mortality in Critically Ill Patients? Infect Control Hosp Epidemiol. 2007;28(12):1367–1373.
• Esme M, Topeli A, Yavuz BB, Akova M. Infections in the Elderly Critically-Ill Patients. Front Med. 2019;6:118.
• Melzer M, Welch C. Outcomes in UK patients with hospital-acquired bacteraemia and the risk of catheter-associated urinary tract infections. Postgrad Med J. 2013;89(1052):329–334.
• Van der Kooi TII, de Boer AS, Manniën J, Wille JC, Beaumont MT, Mooi BW et al. Incidence and risk factors of device-associated infections and associated mortality at the intensive care in the Dutch surveillance system. Intensive Care Med. 2007;33(2):271–278.
• Gomila A, Carratalà J, Eliakim-Raz N, Shaw E, Tebé C, Wolkewitz M et al. Clinical outcomes of hospitalised patients with catheter-associated urinary tract infection in countries with a high rate of multidrug-resistance: The COMBACTE-MAGNET RESCUING study. Antimicrob Resist Infect Control. 2019;8:1–8.
• Liu X, Sai F, Li L, Zhu C, Huang H. Clinical characteristics and risk factors of catheter-associated urinary tract infections caused by Klebsiella Pneumoniae. Ann Palliat Med. 2020;9(5):2668–2677.
• Kose S, Atalay S, Odemis I, Adar P. Antibiotic Susceptibility of Pseudomonas aeruginosa Strains Isolated from Various Clinical Specimens. ANKEM Derg. 2014;28(3):100–104.
• Ödemiş İ, Köse Ş, Ersan G, Çelik D, Akbulut İ. Evaluation of antibiotic susceptibilities of enterococcus strains isolated from clinical samples of hospitalized patients. Turkish Bull Hyg Exp Biol. 2018;75(4):345–352.
• Zilberberg MD, Nathanson BH, Sulham K, Shorr AF. Multiple antimicrobial resistance and outcomes among hospitalized patients with complicated urinary tract infections in the US, 2013–2018: a retrospective cohort study. BMC Infect Dis. 2021;21(1):1–10.
• Ödemiş İ, Köse Ş, Senger SS, Akbulut İ, Çelik D. The diagnostic value of monocyte chemoattractant protein-1, compared with procalcitonin, c-reactive protein, and lactate in bacteremia estimation for patients with febrile neutropenia. Rev Rom Med Lab. 2020;28(4):419–426.
• Bulur O, Kaplan Efe F, İspir İynem HK, Koç S, Beyan E. Comparison of APACHE II and Modified Charlson Index in Mortality Prediction in Patients at Medical Intensive Care Unit. Osmangazi J Med. 2021;44(3):317-322.
• Morkar DN, Dwivedi M, Patil P. Comparative Study of Sofa, Apache Ii, Saps Ii, as a predictor of mortality in patients of sepsis admitted in medical ICU. J Assoc Physicians India. 2022;70(4):11–12.
• Sheng Y, Zheng W-L, Shi Q-F, Zhang B-Y, Yang G-Y. Clinical characteristics and prognosis in patients with urosepsis from intensive care unit in Shanghai, China: a retrospective bi-centre study. BMC Anesthesiol. 2021;21:296.
• Jiang L, Lin S-H, Wang J, Chu C-K. Prognostic values of procalcitonin and platelet in the patient with urosepsis. Medicine (Baltimore). 2021;100(27):e26555.